Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting

Proteomics has revealed that many proteins are present in unexpected cellular locations. Moreover, it is increasingly recognized that proteins can translocate between intracellular and extracellular compartments in non-conventional ways. This increases gene pleiotrophy as the diverse functions of the protein that the gene encodes are dependent on the cellular location. Given that trafficking drug targets may exist in various forms — often with completely different functions — in multiple cellular compartments, careful interpretation of proteomics data is needed for an accurate understanding of gene function. This Perspective is intended to inspire the investigation of unusual protein localizations, rather than assuming that they are due to mislocalization or artefacts. Given a fair chance, proteomics could reveal novel and unforeseen biology with important ramifications for target validation in drug discovery.

[1]  I. Ghiran,et al.  Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule* , 2003, Journal of Biological Chemistry.

[2]  G von Heijne,et al.  Signal sequences. The limits of variation. , 1985, Journal of molecular biology.

[3]  Paul Workman,et al.  Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. , 2007, Cancer research.

[4]  Walter Kolch,et al.  The molecular make-up of a tumour: proteomics in cancer research. , 2005, Clinical science.

[5]  K. Tracey,et al.  The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.

[6]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[7]  P. Hains,et al.  Proteome Analysis of Vinca Alkaloid Response and Resistance in Acute Lymphoblastic Leukemia Reveals Novel Cytoskeletal Alterations* , 2003, Journal of Biological Chemistry.

[8]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[9]  H. Rauvala,et al.  Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.

[10]  D. Mccormick Sequence the Human Genome , 1986, Bio/Technology.

[11]  M. Lotz,et al.  Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification , 2007, Molecular and Cellular Biology.

[12]  Bonnie F. Sloane,et al.  Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.

[13]  Hitoshi Takahashi,et al.  Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  Thomas C. Südhof,et al.  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.

[15]  Emma J. Blott,et al.  Secretory lysosomes , 2002, Nature Reviews Molecular Cell Biology.

[16]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[17]  L. Lum,et al.  Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival* , 1999, Journal of Biological Chemistry.

[18]  Christopher M Overall,et al.  Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.

[19]  Kai-Ping Chang,et al.  Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model , 2005, Proteomics.

[20]  P. Marin,et al.  Proteomic Analysis of Astrocytic Secretion in the Mouse , 2003, Journal of Biological Chemistry.

[21]  M. Stack,et al.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Mathews,et al.  RNA binding and phosphorylation determine the intracellular distribution of nuclear factors 90 and 110. , 2005, Journal of molecular biology.

[23]  W. Sadee,et al.  A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. , 2006, Molecular pharmaceutics.

[24]  A. Kungl,et al.  A proteomic snapshot of the human heat shock protein 90 interactome , 2005, FEBS letters.

[25]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[26]  D. Altieri,et al.  Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network , 2007, Cell.

[27]  H. Hoogsteden,et al.  Proteomic analysis of exosomes secreted by human mesothelioma cells. , 2004, The American journal of pathology.

[28]  Rainer Breitling,et al.  What is Systems Biology? , 2010, Front. Physiology.

[29]  W. Nickel Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells , 2005, Traffic.

[30]  D. Kwiatkowski,et al.  Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin , 1988, The Journal of cell biology.

[31]  Jeon-Soo Shin,et al.  HMGB1 Is Phosphorylated by Classical Protein Kinase C and Is Secreted by a Calcium-Dependent Mechanism1 , 2009, The Journal of Immunology.

[32]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[33]  G. Kreitzer,et al.  An Annexin 2 Phosphorylation Switch Mediates p11-dependent Translocation of Annexin 2 to the Cell Surface* , 2004, Journal of Biological Chemistry.

[34]  J. Stow,et al.  Nuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor , 2005, Traffic.

[35]  D. Solit,et al.  Hsp90: the vulnerable chaperone. , 2004, Drug discovery today.

[36]  H. Samaratunga,et al.  Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP , 2004, Clinical Cancer Research.

[37]  J. Reader,et al.  The novel fragment of tyrosyl tRNA synthetase, mini‐ TyrRS, is secreted to induce an angiogenic response in endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Christopher M Overall,et al.  Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. , 2009, Biochemistry.

[39]  M. Goppelt‐Struebe,et al.  Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins , 2006, The FEBS journal.

[40]  Z. Chrzanowska-Lightowlers,et al.  Annexin A2 binds to the localization signal in the 3′ untranslated region of c‐myc mRNA , 2005, The FEBS journal.

[41]  Sunghoon Kim,et al.  Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. , 2005, Trends in biochemical sciences.

[42]  Pier Paolo Pandolfi,et al.  Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation , 2007, Nature Reviews Cancer.

[43]  F L STONE,et al.  TWO SIDES OF THE COIN. , 1963, Journal of medical education.

[44]  A. Kungl,et al.  A proteomic approach towards the Hsp90‐dependent ubiquitinylated proteome , 2007, Proteomics.

[45]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[46]  B. Eustace,et al.  Extracellular Roles for the Molecular Chaperone, HSP90 , 2004, Cell cycle.

[47]  D. Strickland,et al.  Low density lipoprotein receptor–related protein is a calreticulin coreceptor that signals focal adhesion disassembly , 2003, The Journal of cell biology.

[48]  Andrew Emili,et al.  Proteomic methods for drug target discovery. , 2008, Current opinion in chemical biology.

[49]  J. Piatigorsky,et al.  Gene sharing in lens and cornea: facts and implications , 1998, Progress in Retinal and Eye Research.

[50]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[51]  M. Selsted,et al.  Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. , 1984, The Journal of biological chemistry.

[52]  S. Cheung,et al.  Atypical localization of membrane type 1‐matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma , 2007, Molecular carcinogenesis.

[53]  H. Rauvala,et al.  Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. , 1991, The Journal of biological chemistry.

[54]  R. Laskey,et al.  Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.

[55]  H. Pollard,et al.  A rise in nuclear calcium translocates annexins IV and V to the nuclear envelope , 1996, FEBS letters.

[56]  A. Strongin,et al.  Mislocalization and unconventional functions of cellular MMPs in cancer , 2006, Cancer and Metastasis Reviews.

[57]  L. Lau,et al.  The Angiogenic Factors Cyr61 and Connective Tissue Growth Factor Induce Adhesive Signaling in Primary Human Skin Fibroblasts* , 2001, The Journal of Biological Chemistry.

[58]  Steven A Carr,et al.  Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[59]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[60]  J. Frydman,et al.  The Hsp90 mosaic: a picture emerges , 2009, Nature Structural &Molecular Biology.

[61]  K. Meyer-Siegler,et al.  Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. , 1993, Nucleic acids research.

[62]  Takanori Aoki,et al.  Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165* , 2002, The Journal of Biological Chemistry.

[63]  K Meyer-Siegler,et al.  A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[65]  M. Bogyo,et al.  A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. , 2004, Molecular cell.

[66]  S. Munro,et al.  A C-terminal signal prevents secretion of luminal ER proteins , 1987, Cell.

[67]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  F. Jurnak,et al.  Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor , 2005, Molecular Cancer Therapeutics.

[69]  Stephen M. Mount,et al.  The genome sequence of Drosophila melanogaster. , 2000, Science.

[70]  V. Devita,et al.  Trials and tribulations , 2008, Nature Clinical Practice Oncology.

[71]  P. Schimmel,et al.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.

[72]  L. Rothfield,et al.  RNaseE and the other constituents of the RNA degradosome are components of the bacterial cytoskeleton , 2007, Proceedings of the National Academy of Sciences.

[73]  L. Zolla,et al.  A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. , 2008, Biochimica et biophysica acta.

[74]  A. Fusco,et al.  Retraction: Identification of new high mobility group A1 associated proteins , 2007, Proteomics.

[75]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[76]  M. Bogyo,et al.  Increased Expression and Activity of Nuclear Cathepsin L in Cancer Cells Suggests a Novel Mechanism of Cell Transformation , 2007, Molecular Cancer Research.

[77]  S Subramani,et al.  Import of peroxisomal matrix and membrane proteins. , 2000, Annual review of biochemistry.

[78]  C. Overall,et al.  Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co , 2007, Molecular and Cellular Biology.

[79]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[80]  F. Blasi,et al.  Metalloproteases Cleave the Urokinase-Type Plasminogen Activator Receptor in the D1-D2 Linker Region and Expose Epitopes not Present in the intact Soluble Receptor , 2002, Thrombosis and Haemostasis.

[81]  M. Vadas,et al.  The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. , 2006, Drug discovery today.

[82]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[83]  D. Waisman,et al.  Annexin A2 Is a Novel RNA-binding Protein , 2004, Journal of Biological Chemistry.

[84]  C. López-Otín,et al.  Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.

[85]  V. Vasiliou,et al.  ALDH3A1: a corneal crystallin with diverse functions. , 2007, Experimental eye research.

[86]  S. Vandenberg,et al.  Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. , 2001, Journal of cell science.

[87]  C. Overall,et al.  Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding , 2008, Molecular and Cellular Biology.

[88]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[89]  J. Tschopp,et al.  The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes , 1993, The Journal of experimental medicine.

[90]  G. Cagney,et al.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.

[91]  S. Lepreux,et al.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. , 2006, The American journal of pathology.

[92]  H. Knull,et al.  Association of glycolytic enzymes with the cytoskeleton. , 1992, Current topics in cellular regulation.

[93]  Terence C W Poon,et al.  Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. , 2006, Journal of proteome research.

[94]  Christopher M Overall,et al.  Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. , 2008, Molecular & cellular proteomics : MCP.

[95]  J. Reynolds,et al.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. , 1981, The Biochemical journal.

[96]  Q. Gong,et al.  Protective Effect of Antagonist of High‐mobility Group Box 1 on Lipopolysaccharide‐Induced Acute Lung Injury in Mice , 2009, Scandinavian journal of immunology.

[97]  I. Gotoh,et al.  Membrane‐type 1 matrix metalloproteinase cytoplasmic tail binding protein‐1 (MTCBP‐1) acts as an eukaryotic aci‐reductone dioxygenase (ARD) in the methionine salvage pathway , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[98]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[99]  Wei Hu,et al.  Proteomics in cancer research , 2002, International Journal of Gynecologic Cancer.

[100]  M. Gurney,et al.  Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences , 1988, Nature.

[101]  K. Sakaguchi,et al.  Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth , 1998, The Journal of experimental medicine.

[102]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[103]  Z. Werb ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.

[104]  Franck Molina,et al.  Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer , 2004, Fundamental & clinical pharmacology.

[105]  H. Ariga,et al.  A major cellular substrate for protein kinases, annexin II, is a DNA‐binding protein , 1994, FEBS letters.

[106]  K. Tan,et al.  Identification and characterization of mErk5-T, a novel Erk5/Bmk1 splice variant. , 2005, Gene.

[107]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[108]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[109]  L. Pannell,et al.  Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. , 2007, Journal of proteome research.

[110]  R. Schulz Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. , 2007, Annual review of pharmacology and toxicology.

[111]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[112]  A. Strongin,et al.  Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Exhibits an Important Intracellular Cleavage Function and Causes Chromosome Instability* , 2005, Journal of Biological Chemistry.

[113]  F. D’Acquisto,et al.  Annexin 1 Cleavage in Activated Neutrophils , 2007, Journal of Biological Chemistry.

[114]  L. Pearl,et al.  A Two-Hybrid Screen of the Yeast Proteome for Hsp90 Interactors Uncovers a Novel Hsp90 Chaperone Requirement in the Activity of a Stress-Activated Mitogen-Activated Protein Kinase, Slt2p (Mpk1p) , 2005, Eukaryotic Cell.

[115]  A. Jimeno,et al.  Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer , 2008, Molecular Cancer Therapeutics.

[116]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[117]  D. Newton,et al.  Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin , 2007, Clinical Cancer Research.

[118]  Y. Naot,et al.  Cloning of a Glucose Phosphate Isomerase/Neuroleukin-Like Sperm Antigen Involved in Sperm Agglutination1 , 2000, Biology of reproduction.

[119]  J. Vishwanatha,et al.  Regulation of nucleo-cytoplasmic shuttling of human annexin A2—a proposed mechanism , 2007, Molecular and Cellular Biochemistry.

[120]  Haichao Wang,et al.  Therapeutic potential of HMGB1-targeting agents in sepsis , 2008, Expert Reviews in Molecular Medicine.

[121]  K. Brand,et al.  Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. , 1988, Cancer research.

[122]  P. Schimmel,et al.  A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase. , 2004, Nucleic acids research.

[123]  W. Coetzee,et al.  The Glycolytic Enzymes, Glyceraldehyde-3-phosphate Dehydrogenase, Triose-phosphate Isomerase, and Pyruvate Kinase Are Components of the KATP Channel Macromolecular Complex and Regulate Its Function* , 2005, Journal of Biological Chemistry.

[124]  Y. Minami,et al.  Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1 , 2007, European journal of haematology.

[125]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[126]  S. Zucker,et al.  Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.

[127]  K. Tracey,et al.  Extracellular role of HMGB1 in inflammation and sepsis , 2004, Journal of internal medicine.

[128]  Liang Xie,et al.  Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[129]  D. Solit,et al.  Development and application of Hsp90 inhibitors. , 2008, Drug discovery today.

[130]  Wei Li,et al.  Extracellular heat shock protein‐90α: linking hypoxia to skin cell motility and wound healing , 2007, The EMBO journal.

[131]  J. Wegiel,et al.  Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils , 2000, Brain Research.

[132]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[133]  L. Lund,et al.  Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. , 1992, The Journal of biological chemistry.

[134]  K. Harigaya,et al.  Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid‐potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment , 1990, FEBS letters.

[135]  H. Rauvala,et al.  Neurite growth-promoting protein (amphoterin, p30) binds syndecan. , 1992, Experimental cell research.

[136]  W. Deal,et al.  Reversible dissociation of tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase into dimers or monomers by adenosine triphosphate. , 1969, The Journal of biological chemistry.

[137]  C. Rozanas,et al.  Capabilities using 2-D DIGE in proteomics research : the new gold standard for 2-D gel electrophoresis. , 2008, Methods in molecular biology.

[138]  S. Tatarano,et al.  Nuclear translocation of ADAM‐10 contributes to the pathogenesis and progression of human prostate cancer , 2007, Cancer science.

[139]  S. Werner,et al.  Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.

[140]  Andrew Emili,et al.  Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.

[141]  M. Kelley,et al.  The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. , 2007, Molecular aspects of medicine.

[142]  K. Tracey,et al.  HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.

[143]  Anindya Sinha,et al.  Some like it hot . . . , 1992, Nature.

[144]  Sunghoon Kim,et al.  Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[145]  V. Herzog,et al.  Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. , 1996, Endocrinology.

[146]  R. Cardone,et al.  The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis , 2005, Nature Reviews Cancer.

[147]  U. Novak,et al.  Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members , 2006, Journal of Cell Science.

[148]  J. Riordan,et al.  Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. , 1991, Biochemistry.

[149]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[150]  W. Holzgreve,et al.  Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? , 2007, Seminars in Immunopathology.

[151]  K. Elenitoba-Johnson,et al.  Proteome‐wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells , 2007, Proteomics.

[152]  R. Kellner,et al.  Annexin II is a major component of fusogenic endosomal vesicles , 1993, The Journal of cell biology.

[153]  C. Overall,et al.  Proteomic discovery of protease substrates. , 2007, Current opinion in chemical biology.

[154]  B. Cauwe,et al.  The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.

[155]  J. Štokrová,et al.  HMGB1 interacts with human topoisomerase IIα and stimulates its catalytic activity , 2007, Nucleic acids research.

[156]  Xiaodan Yu,et al.  Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells. , 2008, Journal of proteome research.

[157]  R. Kelly,et al.  Protein translocation: Rehearsing the ABCs , 1996, Current Biology.

[158]  B. Freeman,et al.  The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities , 2007, Molecular and Cellular Biology.

[159]  M. Gurney,et al.  Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. , 1986, Science.

[160]  M. Ahram,et al.  A proteomic approach to characterize protein shedding , 2005, Proteomics.

[161]  G. Manfioletti,et al.  Interaction proteomics of the HMGA chromatin architectural factors , 2008, Proteomics.

[162]  T. Omura,et al.  Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria. , 1998, Journal of biochemistry.

[163]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[164]  David E. Misek,et al.  Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function* , 2003, The Journal of Biological Chemistry.

[165]  R. Black,et al.  A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes , 1995, The Journal of experimental medicine.

[166]  J. García,et al.  Functional and quantitative proteomics using SILAC in cancer research , 2008 .

[167]  T. Veenstra,et al.  The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.

[168]  P. Workman,et al.  Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone , 2000, Oncogene.

[169]  M. Takigawa,et al.  Novel Transcription Factor-Like Function of Human Matrix Metalloproteinase 3 Regulating the CTGF/CCN2 Gene , 2008, Molecular and Cellular Biology.

[170]  H. Erickson,et al.  Extracellular annexin II. , 1997, The international journal of biochemistry & cell biology.

[171]  Constance J Jeffery,et al.  Multifunctional proteins: examples of gene sharing , 2003, Annals of medicine.

[172]  L. Mao,et al.  Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor , 2003, Proteomics.

[173]  Sabine S. Lange,et al.  High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage , 2008, Proceedings of the National Academy of Sciences.

[174]  C. Overall,et al.  Cytokine Substrates: MMP Regulation of Inflammatory Signaling Molecules , 2008 .

[175]  E. Melloni,et al.  3 – Selective Pro-Inflammatory Activation of Astrocytes by High Mobility Group Box 1 Protein Signaling , 2010 .

[176]  G. Feuerstein,et al.  Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin αIIb cytoplasmic domain , 2006 .

[177]  J. Reynolds,et al.  Purification of rabbit bone inhibitor of collagenase. , 1981, The Biochemical journal.

[178]  Sarat Chandarlapaty,et al.  SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers , 2008, Clinical Cancer Research.

[179]  J. Foidart,et al.  Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.

[180]  O. Silvennoinen,et al.  STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.

[181]  Ruedi Aebersold,et al.  Quantitative proteomics by stable isotope labeling and mass spectrometry. , 2007, Methods in molecular biology.

[182]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[183]  B. Fingleton MMPs as therapeutic targets--still a viable option? , 2008, Seminars in cell & developmental biology.

[184]  E. Mariman,et al.  Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines , 2004, Cellular and Molecular Life Sciences CMLS.

[185]  K. Elenitoba-Johnson,et al.  Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells*S , 2004, Molecular & Cellular Proteomics.

[186]  L. Neckers,et al.  Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness , 2004, Nature Cell Biology.

[187]  Sunghoon Kim,et al.  Aminoacyl-tRNA synthetase complexes: beyond translation , 2004, Journal of Cell Science.

[188]  L. Matrisian,et al.  Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.

[189]  L. Zolla Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins , 2008, Drug Discovery Today.

[190]  T. Shiomi,et al.  Membrane-type 1 Matrix Metalloproteinase Cytoplasmic Tail-binding Protein-1 Is a New Member of the Cupin Superfamily , 2004, Journal of Biological Chemistry.

[191]  M. Hollenberg,et al.  Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration , 2006, Proceedings of the National Academy of Sciences.

[192]  A. Singer,et al.  The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype‐independent CD3 complexes. , 1995, The EMBO journal.

[193]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[194]  M. Tomita,et al.  Nuclear Export Signal Consensus Sequences Defined Using a Localization‐Based Yeast Selection System , 2008, Traffic.

[195]  Philippe Amouyel,et al.  Two‐dimensional maps and databases of the human macrophage proteome and secretome , 2004, Proteomics.

[196]  Georg Schett,et al.  Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.

[197]  M. Moses,et al.  Making the cut: protease-mediated regulation of angiogenesis. , 2006, Experimental cell research.

[198]  M. Stack,et al.  Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. , 2008, Seminars in cell & developmental biology.

[199]  A. Chiarugi,et al.  Relevance of high-mobility group protein box 1 to neurodegeneration. , 2007, International review of neurobiology.

[200]  R. Soldi,et al.  Secretion without Golgi , 2008, Journal of cellular biochemistry.

[201]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[202]  C. Czupalla,et al.  Proteomic Analysis of Lysosomal Acid Hydrolases Secreted by Osteoclasts , 2006, Molecular & Cellular Proteomics.

[203]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[204]  C. Overall,et al.  Towards third generation matrix metalloproteinase inhibitors for cancer therapy , 2006, British Journal of Cancer.

[205]  R. Dwek,et al.  The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG‐1 metastasis markers and leads to the identification of DJ‐1 as a potential serum biomarker , 2006, International journal of cancer.

[206]  C. López-Otín,et al.  Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.

[207]  A. M. Houghton,et al.  Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. , 2006, Cancer research.

[208]  C. Röcken,et al.  Ectopeptidases in tumour biology: a review. , 2006, Histology and histopathology.

[209]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[210]  U. Banerji,et al.  Heat Shock Protein 90 as a Drug Target: Some Like It Hot , 2009, Clinical Cancer Research.

[211]  M. Manjili,et al.  Comment on “Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma” , 2006, The Journal of Immunology.

[212]  M. Michalak,et al.  The ins and outs of calreticulin: from the ER lumen to the extracellular space. , 2001, Trends in cell biology.

[213]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[214]  G. Struhl,et al.  Nuclear Access and Action of Notch In Vivo , 1998, Cell.

[215]  L. Pearl,et al.  A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s , 2009, The FEBS journal.

[216]  C. Overall,et al.  Protease proteomics: revealing protease in vivo functions using systems biology approaches. , 2008, Molecular aspects of medicine.

[217]  A. Raz,et al.  The role of autocrine motility factor in tumor and tumor microenvironment , 2007, Cancer and Metastasis Reviews.

[218]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[219]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[220]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[221]  U. Andersson,et al.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease , 2008, Arthritis research & therapy.

[222]  R. Aebersold,et al.  Proteomics: the first decade and beyond , 2003, Nature Genetics.

[223]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[224]  C. Overall Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. , 2004, The Biochemical journal.

[225]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[226]  B. Fingleton MMP Inhibitor Clinical Trials – The Past, Present, and Future , 2008 .

[227]  D. Thompson,et al.  Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.

[228]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[229]  Jean Y. J. Wang,et al.  Exploiting the promiscuity of imatinib , 2009, Journal of biology.

[230]  K. Sakaguchi,et al.  Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. , 1999, Blood.

[231]  H. Huttunen,et al.  Regulation of cell migration by amphoterin. , 2000, Journal of cell science.

[232]  T. Südhof,et al.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.

[233]  M. Presta,et al.  Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.

[234]  D. Edwards The cancer degradome : proteases and cancer biology , 2008 .

[235]  L. Pearl,et al.  The Hsp90 molecular chaperone: an open and shut case for treatment. , 2008, The Biochemical journal.

[236]  Philippe Amouyel,et al.  The proteome and secretome of human arterial smooth muscle cells , 2005, Proteomics.

[237]  M. Belghazi,et al.  Human epididymal secretome and proteome , 2006, Molecular and Cellular Endocrinology.

[238]  Jeon-Soo Shin,et al.  Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion1 , 2006, The Journal of Immunology.

[239]  T Shinozaki,et al.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.

[240]  G. Goodwin,et al.  Interactions of a purified non-histone chromosomal protein with DNA and histone. , 1974, European journal of biochemistry.

[241]  P. Stephens,et al.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.

[242]  Frank A Witzmann,et al.  Pharmacoproteomics in drug development , 2003, The Pharmacogenomics Journal.

[243]  Y. Fujiwara,et al.  Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry , 2007, Molecular and Cellular Biochemistry.

[244]  R. Milo,et al.  Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.

[245]  O. Yizhar,et al.  Nonconventional Trafficking of Ras Associated with Ras Signal Organization , 2006, Traffic.

[246]  W. Pratt,et al.  The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts* , 2008, Journal of Biological Chemistry.

[247]  S. Dower,et al.  Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. , 1994, Journal of immunology.

[248]  T. Rabilloud,et al.  Toward a better analysis of secreted proteins: the example of the myeloid cells secretome , 2007, Proteomics.

[249]  R. Cramer,et al.  PIGOK: Linking protein identity to gene ontology and function. , 2006, Journal of Proteome Research.

[250]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[251]  E. Brown,et al.  Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.

[252]  S. Normark,et al.  Neutrophil extracellular traps: casting the NET over pathogenesis. , 2007, Current opinion in microbiology.

[253]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.